ReShape Lifesciences Announces Submission for Approval of ReShape Balloon(TM) in Canada

SAN CLEMENTE, Calif., May 10, 2018 -- (Healthcare Sales & Marketing Network) -- ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today the submission of an appli... Devices, Regulatory ReShape Lifesciences, ReShape Balloon, obesity
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news